BioNTech SE (BNTX) Other Non-Current Assets (2018 - 2025)

BioNTech SE's (BNTX) quarterly Other Non-Current Assets came in at $202.3 million in Q4 2025, down 10.99% year-on-year from $227.3 million in Q4 2024, and down 40.92% quarter-over-quarter from $342.4 million in Q3 2025.

BioNTech SE (BNTX) Other Non-Current Assets (2018 - 2025) Analysis & Trends

BioNTech SE has disclosed Other Non-Current Assets across 7 years of filings, most recently posting $202.3 million for Q4 2025.

  • Other Non-Current Assets for Q4 2025 came in at $202.3 million, down 10.99% year-over-year; the trailing twelve-month figure through Dec 2025 was $202.3 million (down 10.99% YoY), and the FY2025 annual result was $196.4 million, down 13.61% from the prior year.
  • Other Non-Current Assets came in at $202.3 million for Q4 2025 at BioNTech SE, down from $342.4 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $386.9 million in Q2 2024 to a low of $49.7 million in Q2 2022.
  • The 5-year median for Other Non-Current Assets is $231.2 million (2023), against an average of $226.3 million.
  • Across the five-year window, Other Non-Current Assets soared 364.92% in 2023 and slumped 37.1% in 2025, its largest moves.
  • BioNTech SE's Other Non-Current Assets stood at $129.7 million in 2021, then climbed by 26.46% to $164.0 million in 2022, then jumped by 84.24% to $302.2 million in 2023, then retreated by 24.8% to $227.3 million in 2024, then slipped by 10.99% to $202.3 million in 2025.
  • The last three Other Non-Current Assets figures came in at $202.3 million (Q4 2025), $342.4 million (Q3 2025), and $243.4 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn 12.40 Mn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - 60,000.00
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 1.26 Bn
9 Abivax 90.15 Bn 90.15 Bn - -
10 BioNTech SE 27.31 Bn 9.99 Bn 668.28 Mn 202.31 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 202.31 Mn
Sep 30, 2025 342.42 Mn
Jun 30, 2025 243.37 Mn
Mar 31, 2025 246.46 Mn
Dec 31, 2024 227.29 Mn
Sep 30, 2024 302.89 Mn
Jun 30, 2024 386.93 Mn
Mar 31, 2024 366.10 Mn
Dec 31, 2023 302.23 Mn
Sep 30, 2023 311.55 Mn
Jun 30, 2023 231.18 Mn
Mar 31, 2023 183.86 Mn
Sep 30, 2022 164.05 Mn
Jun 30, 2022 49.72 Mn
Mar 31, 2022 72.84 Mn
Dec 31, 2021 129.73 Mn
Mar 31, 2021 83.95 Mn
Dec 31, 2019 10.04 Mn
Sep 30, 2019 10.40 Mn
Dec 31, 2018 10.46 Mn